Diversified Trust Co Decreases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Diversified Trust Co reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 36,761 shares of the company's stock after selling 12,595 shares during the quarter. Diversified Trust Co's holdings in HCA Healthcare were worth $12,703,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of HCA. Tranquility Partners LLC lifted its stake in shares of HCA Healthcare by 1.2% in the 1st quarter. Tranquility Partners LLC now owns 16,645 shares of the company's stock worth $5,752,000 after acquiring an additional 195 shares during the period. PDS Planning Inc boosted its holdings in HCA Healthcare by 21.7% in the 1st quarter. PDS Planning Inc now owns 1,116 shares of the company's stock valued at $386,000 after purchasing an additional 199 shares in the last quarter. KG&L Capital Management LLC raised its stake in shares of HCA Healthcare by 13.2% during the 1st quarter. KG&L Capital Management LLC now owns 4,086 shares of the company's stock worth $1,412,000 after buying an additional 477 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in HCA Healthcare by 4.8% during the first quarter. Sequoia Financial Advisors LLC now owns 3,225 shares of the company's stock worth $1,114,000 after acquiring an additional 149 shares during the period. Finally, Perigon Wealth Management LLC raised its position in HCA Healthcare by 2.3% in the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after acquiring an additional 40 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Royal Bank Of Canada reiterated an "outperform" rating and issued a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Finally, Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the company an "overweight" rating in a research note on Monday, June 2nd. Seven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $394.33.

HCA Healthcare Trading Up 0.4%

HCA traded up $1.34 during trading on Friday, hitting $379.00. The company's stock had a trading volume of 1,554,834 shares, compared to its average volume of 1,476,066. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm's 50 day moving average price is $365.66 and its 200-day moving average price is $336.33. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The stock has a market cap of $91.18 billion, a PE ratio of 16.85, a PEG ratio of 1.29 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period last year, the company earned $5.36 EPS. The firm's quarterly revenue was up 5.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 12.81%.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.